Merck (MRK), Sanofi (SNY) and Novartis (NVS) report third-quarter results. FDA approves Pfizers (PFE) Penbraya and Eli Lillys (LLY) Omvoh…
On Eli Lillys (LLY) third-quarter conference call, investor focus is likely to be on the sales of its new diabetes…
…
Hundreds of online sellers are offering Eli Lilly’ & Co.’s LLY retatrutide weight-loss drug for sale, even though the drug…
…
…
The effort comes after Sanofi, Eli Lilly and Novo Nordisk announced sweeping insulin price cuts earlier this year.…
Eli Lilly and Novo Nordisk are both battling demand issues for flagship treatments.…
…
…
This month has been more kind to stocks than last. Our top performers at the halfway mark include Foot Locker…
Whats good for Novo Nordisks Ozempic is also good for Eli Lillys Mounjaro.…
Whats good for Novo Nordisks Ozempic is also good for Eli Lillys Mounjaro.…
Two experts see major challenges facing the adoption of Novo Nordisk and Eli Lillys obesity drugs.…
Eli Lillys (LLY) mirikizumab meets the main goals in a Crohns disease study. PFE, MRK and JNJ provide updates on…
Based on this data, Eli Lilly (LLY) will initiate regulatory submissions worldwide next year seeking regulatory approval for mirikizumab in…
Eli Lillys (LLY) Mounjaro is also being evaluated in clinical studies for patients who are obese or overweight and have…
…
Bristol Myers Squibb, Mirati Therapeutics, Eli Lilly, POINT Biopharma and Pfizer are part of the Zacks top Analyst Blog.…
Broadcom (AVGO) and Eli Lilly (LLY) are among the 15 Club stocks with a streak of annual dividend growth that…
…
…
ROCKVILLE, Md., Oct. 06, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced that Boehringer Ingelheim…
Here are Fridays biggest calls on Wall Street.…
Eli Lilly (LLY) is wisely broadening out its drug pipeline through a series of acquisitions of smaller companies.…
…
…
Eli Lilly: Diabetes & Obesity president to retire; shares dip…
Eli Lilly and Co said on Wednesday that the head of its diabetes and obesity division, Mike Mason, will retire…
Eli Lillys head of diabetes and obesity unit to retire…
American pharmaceutical company Eli Lilly plans to acquire cancer therapy firm Point Biopharma Global, the companies announced Tuesday, an expansion…
Point Biopharma spikes after Eli Lilly agrees to buy cancer-drug firm for $1.4 bn…
Point Biopharmas shares soared 84% in premarket trading.…
…
Eli Lilly and Co has agreed to acquire Point Biopharma Global in an all-cash deal valued at $1.4 billion, the…
Eli Lilly to buy Point Biopharma for $1.4 billion…
Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The "Global Womens Digital Health Market by Type, Distribution Channel, Application…
Today, Nordnet is launching the mutual fund “Nordnet Index Global 125”. Nordnet’s own fund company Nordnet Fonder is co-manager together…
…
APEli Lilly & Co. said Monday the U.S. Food and Drug Administration has issued a complete response letter for its…
Eli Lilly (LLY) was the best-performing Club stock over the past three months, while Foot Locker (FL) was the worst…
Eli Lilly settles whistleblower lawsuit over manufacturing problems…
…
US judge overturns Eli Lillys $176.5 million loss in Teva patent case…
Eli Lilly (LLY) has been the best-performing Club health care stock by a substantial margin, but we continue to believe…
…
Eli Lilly & Co. LLY and Boehringer Ingelheim said Friday that the U.S. Food and Drug Administration has approved their…
Eli Lilly & Co. LLY is best positioned to dominate the fast-growing U.S. market for obesity drugs into the 2030s,…
Shares of the pharmaceutical company have crushed the market so far this year....…
Eli Lilly settled another age discrimination lawsuit for an undisclosed amount, just two months after reaching a $2.4 million settlement…